Temporal trends and determinants of longitudinal change in 25‐hydroxyvitamin D and parathyroid hormone levels

Vitamin D is essential for facilitating calcium absorption and preventing increases in parathyroid hormone (PTH), which can augment bone resorption. Our objectives were to examine serum levels of 25‐hydroxyvitamin D [25(OH)D] and PTH, and factors related to longitudinal change in a population‐based cohort. This is the first longitudinal population‐based study looking at PTH and 25(OH)D levels. We analyzed 3896 blood samples from 1896 women and 829 men in the Canadian Multicentre Osteoporosis Study over a 10‐year period starting in 1995 to 1997. We fit hierarchical models with all available data and adjusted for season. Over 10 years, vitamin D supplement intake increased by 317 (95% confidence interval [CI] 277 to 359) IU/day in women and by 193 (135 to 252) IU/day in men. Serum 25(OH)D (without adjustment) increased by 9.3 (7.3 to 11.4) nmol/L in women and by 3.5 (0.6 to 6.4) nmol/L in men but increased by 4.7 (2.4 to 7.0) nmol/L in women and by 2.7 (−0.6 to 6.2) nmol/L in men after adjustment for vitamin D supplements. The percentage of participants with 25(OH)D levels <50 nmol/L was 29.7% (26.2 to 33.2) at baseline and 19.8% (18.0 to 21.6) at year 10 follow‐up. PTH decreased over 10 years by 7.9 (5.4 to 11.3) pg/mL in women and by 4.6 (0.2 to 9.0) pg/mL in men. Higher 25(OH)D levels were associated with summer, younger age, lower body mass index (BMI), regular physical activity, sun exposure, and higher total calcium intake. Lower PTH levels were associated with younger age and higher 25(OH)D levels in both women and men and with lower BMI and participation in regular physical activity in women only. We have observed concurrent increasing 25(OH)D levels and decreasing PTH levels over 10 years. Secular increases in supplemental vitamin D intake influenced both changes in serum 25(OH)D and PTH levels. © 2012 American Society for Bone and Mineral Research.

[1]  D. Viswanath,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2012, Pediatrics.

[2]  L. Greene-Finestone,et al.  The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use. , 2011, The American journal of clinical nutrition.

[3]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[4]  C. Camargo,et al.  Defining vitamin D status by secondary hyperparathyroidism in the U.S. population , 2011, Journal of Endocrinological Investigation.

[5]  C. Gutiérrez‐Repiso,et al.  Vitamin D deficiency in Spain: a population-based cohort study , 2011, European Journal of Clinical Nutrition.

[6]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[7]  S. Cremers,et al.  Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density , 2011, Osteoporosis International.

[8]  E. Taylor,et al.  Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey , 2011, Osteoporosis International.

[9]  J. Richards,et al.  25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates , 2011, Osteoporosis International.

[10]  M. Calvo,et al.  Despite mandatory fortification of staple foods, vitamin D intakes of Canadian children and adults are inadequate , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[11]  R. Jorde,et al.  Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. , 2010, American journal of epidemiology.

[12]  H. Payette,et al.  Vitamin D supplement consumption is required to achieve a minimal target 25-hydroxyvitamin D concentration of > or = 75 nmol/L in older people. , 2010, The Journal of nutrition.

[13]  I. Reid,et al.  Effects of 25-hydroxyvitamin D level and its change on parathyroid hormone in premenopausal Chinese women , 2010, Osteoporosis International.

[14]  W. Leslie,et al.  Trends in hip fracture rates in Canada. , 2009, JAMA.

[15]  Joseph Hilbe,et al.  Data Analysis Using Regression and Multilevel/Hierarchical Models , 2009 .

[16]  J. Smit,et al.  Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. , 2009, The Journal of clinical endocrinology and metabolism.

[17]  Carlos A Camargo,et al.  Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. , 2009, Archives of internal medicine.

[18]  Mikko P. Björkman,et al.  Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. , 2009, Archives of gerontology and geriatrics.

[19]  L. Joseph,et al.  Calcium and vitamin D intakes in an adult Canadian population. , 2009, Canadian journal of dietetic practice and research : a publication of Dietitians of Canada = Revue canadienne de la pratique et de la recherche en dietetique : une publication des Dietetistes du Canada.

[20]  J. Eisman,et al.  Global vitamin D status and determinants of hypovitaminosis D , 2009, Osteoporosis International.

[21]  Elizabeth A Yetley,et al.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. , 2008, The American journal of clinical nutrition.

[22]  A. Norman.  A vitamin D nutritional cornucopia: new insights concerning the serum 25-hydroxyvitamin D status of the US population. , 2008, The American journal of clinical nutrition.

[23]  B. Clarke.  Relationship Between Serum Parathyroid Hormone Levels, Vitamin D Sufficiency, and Calcium Intake , 2007 .

[24]  J. Aloia,et al.  Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. , 2006, The American journal of clinical nutrition.

[25]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[26]  G. Sigurdsson,et al.  Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. , 2005, JAMA.

[27]  J. Berry,et al.  How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. , 2004, Clinical chemistry.

[28]  J. Pasco,et al.  Seasonal Periodicity of Serum Vitamin D and Parathyroid Hormone, Bone Resorption, and Fractures: The Geelong Osteoporosis Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  R. Vieth,et al.  Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. , 2003, The Journal of clinical endocrinology and metabolism.

[30]  Lawrence Joseph,et al.  Multiple Imputation to Account for Missing Data in a Survey: Estimating the Prevalence of Osteoporosis , 2002, Epidemiology.

[31]  S. Cummings,et al.  A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. , 2001, The Journal of clinical endocrinology and metabolism.

[32]  Jacques P. Brown,et al.  Research Notes: The Canadian Multicentre Osteoporosis Study (CaMos): Background, Rationale, Methods , 1999, Canadian Journal on Aging / La Revue canadienne du vieillissement.

[33]  Andrew M. Gleason,et al.  Calculus (2nd ed.) , 1998 .

[34]  A. Grauer,et al.  Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. , 1998, The Journal of clinical endocrinology and metabolism.

[35]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.